Cita APA (7a ed.)

Tripathi, R., Liu, Z., Jain, A., Lyon, A., Meeks, C., Richards, D., . . . Plattner, R. (2020). Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling. Nature Portfolio.

Cita Chicago Style (17a ed.)

Tripathi, Rakshamani, et al. Combating Acquired Resistance to MAPK Inhibitors in Melanoma by Targeting Abl1/2-mediated Reactivation of MEK/ERK/MYC Signaling. Nature Portfolio, 2020.

Cita MLA (8a ed.)

Tripathi, Rakshamani, et al. Combating Acquired Resistance to MAPK Inhibitors in Melanoma by Targeting Abl1/2-mediated Reactivation of MEK/ERK/MYC Signaling. Nature Portfolio, 2020.